Literature DB >> 34273961

HAVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences.

Ravi Kant1,2, Teemu Smura1,3, Phuoc Thien Truong Nguyen4, Ilya Plyusnin5,2, Tarja Sironen1,2, Olli Vapalahti1,2,3.   

Abstract

BACKGROUND: SARS-CoV-2 related research has increased in importance worldwide since December 2019. Several new variants of SARS-CoV-2 have emerged globally, of which the most notable and concerning currently are the UK variant B.1.1.7, the South African variant B1.351 and the Brazilian variant P.1. Detecting and monitoring novel variants is essential in SARS-CoV-2 surveillance. While there are several tools for assembling virus genomes and performing lineage analyses to investigate SARS-CoV-2, each is limited to performing singular or a few functions separately.
RESULTS: Due to the lack of publicly available pipelines, which could perform fast reference-based assemblies on raw SARS-CoV-2 sequences in addition to identifying lineages to detect variants of concern, we have developed an open source bioinformatic pipeline called HAVoC (Helsinki university Analyzer for Variants of Concern). HAVoC can reference assemble raw sequence reads and assign the corresponding lineages to SARS-CoV-2 sequences.
CONCLUSIONS: HAVoC is a pipeline utilizing several bioinformatic tools to perform multiple necessary analyses for investigating genetic variance among SARS-CoV-2 samples. The pipeline is particularly useful for those who need a more accessible and fast tool to detect and monitor the spread of SARS-CoV-2 variants of concern during local outbreaks. HAVoC is currently being used in Finland for monitoring the spread of SARS-CoV-2 variants. HAVoC user manual and source code are available at https://www.helsinki.fi/en/projects/havoc and https://bitbucket.org/auto_cov_pipeline/havoc , respectively.
© 2021. The Author(s).

Entities:  

Keywords:  Coronavirus; Lineage identification; Reference assembly; SARS-CoV2; Sequence analysis; Variant detection

Mesh:

Year:  2021        PMID: 34273961     DOI: 10.1186/s12859-021-04294-2

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  20 in total

1.  Fairer shares.

Authors:  Jon Cohen; Kai Kupferschmidt
Journal:  Science       Date:  2021-05-28       Impact factor: 47.728

2.  Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2021-02-01

3.  Risk factors for human disease emergence.

Authors:  L H Taylor; S M Latham; M E Woolhouse
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-07-29       Impact factor: 6.237

4.  Zika: the origin and spread of a mosquito-borne virus.

Authors:  Mary Kay Kindhauser; Tomas Allen; Veronika Frank; Ravi Shankar Santhana; Christopher Dye
Journal:  Bull World Health Organ       Date:  2016-02-09       Impact factor: 9.408

5.  Nextstrain: real-time tracking of pathogen evolution.

Authors:  James Hadfield; Colin Megill; Sidney M Bell; John Huddleston; Barney Potter; Charlton Callender; Pavel Sagulenko; Trevor Bedford; Richard A Neher
Journal:  Bioinformatics       Date:  2018-12-01       Impact factor: 6.931

6.  High Resolution analysis of Transmission Dynamics of Sars-Cov-2 in Two Major Hospital Outbreaks in South Africa Leveraging Intrahost Diversity.

Authors:  San Emmanuel James; Sinaye Ngcapu; Aquillah M Kanzi; Houriiyah Tegally; Vagner Fonseca; Jennifer Giandhari; Eduan Wilkinson; Benjamin Chimukangara; Sureshnee Pillay; Lavanya Singh; Maryam Fish; Inbal Gazy; Khulekani Khanyile; Richard Lessells; Tulio de Oliveira
Journal:  medRxiv       Date:  2020-11-16

7.  Host range and emerging and reemerging pathogens.

Authors:  Mark E J Woolhouse; Sonya Gowtage-Sequeria
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

8.  Ebola viral disease outbreak--West Africa, 2014.

Authors:  Meredith G Dixon; Ilana J Schafer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-06-27       Impact factor: 17.586

Review 9.  Emerging Pandemic Diseases: How We Got to COVID-19.

Authors:  David M Morens; Anthony S Fauci
Journal:  Cell       Date:  2020-08-15       Impact factor: 41.582

10.  Face masks and COVID-19: don't let perfect be the enemy of good.

Authors:  Benjamin J Cowling; Gabriel M Leung
Journal:  Euro Surveill       Date:  2020-12
View more
  12 in total

1.  COVID-19 cases in spectators returning to Finland from UEFA Euro 2020 matches in Saint Petersburg.

Authors:  E Sarvikivi; M Salminen; C Savolainen-Kopra; N Ikonen; M Kontio; S Isosomppi; S Jamanca; T Hannila-Handelberg; O Vapalahti; T Smura; M Lappalainen; O Helve
Journal:  Epidemiol Infect       Date:  2022-03-18       Impact factor: 4.434

2.  ClusTRace, a bioinformatic pipeline for analyzing clusters in virus phylogenies.

Authors:  Teemu Smura; Ravi Kant; Ilya Plyusnin; Phuoc Thien Truong Nguyen; Tarja Sironen; Olli Vapalahti
Journal:  BMC Bioinformatics       Date:  2022-05-28       Impact factor: 3.307

3.  High prevalence of an alpha variant lineage with a premature stop codon in ORF7a in Iraq, winter 2020-2021.

Authors:  Nihad A M Al-Rashedi; Hussein Alburkat; Abas O Hadi; Murad G Munahi; Ali Jasim; Alaa Hameed; Basel Saber Oda; Kareem Moamin Lilo; Laith A H AlObaidi; Olli Vapalahti; Tarja Sironen; Teemu Smura
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

4.  Scent dogs in detection of COVID-19: triple-blinded randomised trial and operational real-life screening in airport setting.

Authors:  Anu Kantele; Juuso Paajanen; Soile Turunen; Sari H Pakkanen; Anu Patjas; Laura Itkonen; Elina Heiskanen; Maija Lappalainen; Loic Desquilbet; Olli Vapalahti; Anna Hielm-Björkman
Journal:  BMJ Glob Health       Date:  2022-05

5.  The phylodynamics of SARS-CoV-2 during 2020 in Finland.

Authors:  Phuoc Truong Nguyen; Ravi Kant; Frederik Van den Broeck; Maija T Suvanto; Hussein Alburkat; Jenni Virtanen; Ella Ahvenainen; Robert Castren; Samuel L Hong; Guy Baele; Maarit J Ahava; Hanna Jarva; Suvi Tuulia Jokiranta; Hannimari Kallio-Kokko; Eliisa Kekäläinen; Vesa Kirjavainen; Elisa Kortela; Satu Kurkela; Maija Lappalainen; Hanna Liimatainen; Marc A Suchard; Sari Hannula; Pekka Ellonen; Tarja Sironen; Philippe Lemey; Olli Vapalahti; Teemu Smura
Journal:  Commun Med (Lond)       Date:  2022-06-10

6.  Serological Follow-Up Study Indicates High Seasonal Coronavirus Infection and Reinfection Rates in Early Childhood.

Authors:  Pekka Kolehmainen; Jemna Heroum; Pinja Jalkanen; Moona Huttunen; Laura Toivonen; Varpu Marjomäki; Matti Waris; Teemu Smura; Laura Kakkola; Sisko Tauriainen; Ville Peltola; Ilkka Julkunen
Journal:  Microbiol Spectr       Date:  2022-06-21

7.  ViralFlow: A Versatile Automated Workflow for SARS-CoV-2 Genome Assembly, Lineage Assignment, Mutations and Intrahost Variant Detection.

Authors:  Filipe Zimmer Dezordi; Antonio Marinho da Silva Neto; Túlio de Lima Campos; Pedro Miguel Carneiro Jeronimo; Cleber Furtado Aksenen; Suzana Porto Almeida; Gabriel Luz Wallau
Journal:  Viruses       Date:  2022-01-23       Impact factor: 5.048

8.  Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022.

Authors:  Erika Lindh; Teemu Smura; Soile Blomqvist; Kirsi Liitsola; Hanna Vauhkonen; Laura Savolainen; Jaana Ikonen; Jukka Ronkainen; Jyri Taskila; Tea Taskila; Pertti Sakaranaho; Carita Savolainen-Kopra; Olli Vapalahti; Niina Ikonen
Journal:  Euro Surveill       Date:  2022-04

9.  Low Represented Mutation Clustering in SARS-CoV-2 B.1.1.7 Sublineage Group with Synonymous Mutations in the E Gene.

Authors:  Paolo Giuseppe Bonacci; Dalida Angela Bivona; Dafne Bongiorno; Stefano Stracquadanio; Mariacristina Massimino; Carmelo Bonomo; Alessia Stracuzzi; Paolo Pennisi; Nicolò Musso; Stefania Stefani
Journal:  Diagnostics (Basel)       Date:  2021-12-07

10.  The ViReflow pipeline enables user friendly large scale viral consensus genome reconstruction.

Authors:  Niema Moshiri; Kathleen M Fisch; Amanda Birmingham; Peter DeHoff; Gene W Yeo; Kristen Jepsen; Louise C Laurent; Rob Knight
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.